Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ipsen (IPN.FP)

Ipsen (IPN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ipsen 65 Quai Georges Gorse Billancourt Cedex Boulogne 92100 FRA

P: +33 158335000

Description:

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Key Statistics

Overview:

Market Capitalization, $K 9,527,656
Shares Outstanding, K 82,695
Annual Sales, $ 3,306 M
Annual Net Income, $ 644,400 K
% of Institutional Shareholders 15.97%

Growth:

1-Year Return 3.28%
3-Year Return 39.43%
5-Year Return 5.59%
5-Year Revenue Growth 7.08%
5-Year Earnings Growth 10.56%
5-Year Dividend Growth 3.71%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 7.73
EPS Growth vs. Prev Year -0.01%
Annual Dividend Rate, $ 1.20
Annual Dividend Yield 1.04%
Most Recent Dividend 1.200 on 06/02/23
Next Ex-Dividends Date 06/02/23
Dividend Payable Date 06/06/23
Dividend Payout Ratio 16.22%

IPN.FP Ratios

Ratio
Price/Earnings ttm 15.57
Price/Earnings forward 13.59
Price/Earnings to Growth 6.41
Return-on-Equity % 17.99%
Return-on-Assets % 10.80%
Profit Margin % 19.49%
Debt/Equity 0.07
Price/Sales 2.90
Price/Cash Flow 11.09
Price/Book 2.49
Book Value/Share 46.25
Interest Coverage 21.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar